Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist, 1 a groundbreaking feature within the Libre app 5 designed to help the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback